Merit Medical Systems Stock Net Income
| MM3 Stock | EUR 69.00 1.00 1.47% |
As of the 18th of February 2026, Merit Medical secures the Mean Deviation of 1.5, standard deviation of 2.06, and Risk Adjusted Performance of (0.04). In connection with fundamental indicators, the technical analysis model lets you check existing technical drivers of Merit Medical Systems, as well as the relationship between them. Please verify Merit Medical Systems mean deviation, standard deviation, information ratio, as well as the relationship between the coefficient of variation and variance to decide if Merit Medical Systems is priced some-what accurately, providing market reflects its recent price of 69.0 per share.
Merit Medical Total Revenue |
|
Gross Profit | Profit Margin | Market Capitalization 4.1 B | Enterprise Value Revenue 3.568 | Revenue |
| Last Reported | Projected for Next Year | ||
| Net Income From Continuing Ops | 138.4 M | 145.3 M | |
| Net Income Applicable To Common Shares | 85.7 M | 90 M | |
| Net Income | 138.4 M | 145.3 M |
Merit | Net Income |
The Net Income trend for Merit Medical Systems offers valuable insights into the company's financial trajectory and strategic direction. By examining multi-year patterns, investors can identify whether Merit Medical is strengthening or weakening its position, and how this metric correlates with broader market conditions and industry benchmarks.
Latest Merit Medical's Net Income Growth Pattern
Below is the plot of the Net Income of Merit Medical Systems over the last few years. Net income is one of the most important fundamental items in finance. It plays a large role in Merit Medical Systems financial statement analysis. It represents the amount of money remaining after all of Merit Medical Systems operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue. It is Merit Medical's Net Income historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Merit Medical's overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported 120.36 M | 10 Years Trend |
|
Net Income |
| Timeline |
Merit Net Income Regression Statistics
| Arithmetic Mean | 49,730,625 | |
| Coefficient Of Variation | 95.11 | |
| Mean Deviation | 38,161,471 | |
| Median | 23,802,000 | |
| Standard Deviation | 47,298,870 | |
| Sample Variance | 2237.2T | |
| Range | 155.2M | |
| R-Value | 0.77 | |
| Mean Square Error | 986.9T | |
| R-Squared | 0.59 | |
| Significance | 0.0003 | |
| Slope | 7,172,842 | |
| Total Sum of Squares | 35794.9T |
Merit Net Income History
Merit Medical 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Merit Medical's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Merit Medical.
| 11/20/2025 |
| 02/18/2026 |
If you would invest 0.00 in Merit Medical on November 20, 2025 and sell it all today you would earn a total of 0.00 from holding Merit Medical Systems or generate 0.0% return on investment in Merit Medical over 90 days. Merit Medical is related to or competes with Cerence, TELES Informationstech, BIOTIME, MBIA, MBIA, and ANGES MG. Merit Medical Systems, Inc. manufactures and markets disposable medical devices for interventional, diagnostic, and ther... More
Merit Medical Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Merit Medical's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Merit Medical Systems upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.08) | |||
| Maximum Drawdown | 14.21 | |||
| Value At Risk | (2.88) | |||
| Potential Upside | 2.96 |
Merit Medical Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Merit Medical's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Merit Medical's standard deviation. In reality, there are many statistical measures that can use Merit Medical historical prices to predict the future Merit Medical's volatility.| Risk Adjusted Performance | (0.04) | |||
| Jensen Alpha | (0.12) | |||
| Total Risk Alpha | (0.24) | |||
| Treynor Ratio | 0.7293 |
Merit Medical February 18, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.04) | |||
| Market Risk Adjusted Performance | 0.7393 | |||
| Mean Deviation | 1.5 | |||
| Coefficient Of Variation | (1,788) | |||
| Standard Deviation | 2.06 | |||
| Variance | 4.25 | |||
| Information Ratio | (0.08) | |||
| Jensen Alpha | (0.12) | |||
| Total Risk Alpha | (0.24) | |||
| Treynor Ratio | 0.7293 | |||
| Maximum Drawdown | 14.21 | |||
| Value At Risk | (2.88) | |||
| Potential Upside | 2.96 | |||
| Skewness | (0.13) | |||
| Kurtosis | 2.86 |
Merit Medical Systems Backtested Returns
Merit Medical Systems has Sharpe Ratio of -0.0397, which conveys that the firm had a -0.0397 % return per unit of risk over the last 3 months. Merit Medical exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please verify Merit Medical's Standard Deviation of 2.06, risk adjusted performance of (0.04), and Mean Deviation of 1.5 to check out the risk estimate we provide. The company secures a Beta (Market Risk) of -0.17, which conveys not very significant fluctuations relative to the market. As returns on the market increase, returns on owning Merit Medical are expected to decrease at a much lower rate. During the bear market, Merit Medical is likely to outperform the market. At this point, Merit Medical Systems has a negative expected return of -0.0835%. Please make sure to verify Merit Medical's maximum drawdown, potential upside, kurtosis, as well as the relationship between the value at risk and skewness , to decide if Merit Medical Systems performance from the past will be repeated at some point in the near future.
Auto-correlation | 0.47 |
Average predictability
Merit Medical Systems has average predictability. Overlapping area represents the amount of predictability between Merit Medical time series from 20th of November 2025 to 4th of January 2026 and 4th of January 2026 to 18th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Merit Medical Systems price movement. The serial correlation of 0.47 indicates that about 47.0% of current Merit Medical price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.47 | |
| Spearman Rank Test | 0.0 | |
| Residual Average | 0.0 | |
| Price Variance | 12.58 |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
| Competition |
Merit Operating Income
Operating Income |
|
Based on the recorded statements, Merit Medical Systems reported net income of 120.36 M. This is 64.73% lower than that of the Health Care Equipment & Supplies sector and 20.8% higher than that of the Health Care industry. The net income for all Germany stocks is 78.92% higher than that of the company.
Merit Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Merit Medical's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Merit Medical could also be used in its relative valuation, which is a method of valuing Merit Medical by comparing valuation metrics of similar companies.Merit Medical is currently under evaluation in net income category among its peers.
Merit Fundamentals
| Return On Equity | 0.083 | ||||
| Return On Asset | 0.0428 | ||||
| Profit Margin | 0.08 % | ||||
| Operating Margin | 0.11 % | ||||
| Current Valuation | 4.44 B | ||||
| Shares Outstanding | 59.29 M | ||||
| Shares Owned By Insiders | 2.22 % | ||||
| Shares Owned By Institutions | 97.78 % | ||||
| Price To Earning | 46.88 X | ||||
| Price To Book | 3.13 X | ||||
| Price To Sales | 2.77 X | ||||
| Revenue | 1.36 B | ||||
| Gross Profit | 715.9 M | ||||
| EBITDA | 291.78 M | ||||
| Net Income | 120.36 M | ||||
| Cash And Equivalents | 35.18 M | ||||
| Cash Per Share | 0.64 X | ||||
| Total Debt | 1.04 B | ||||
| Debt To Equity | 50.80 % | ||||
| Current Ratio | 2.42 X | ||||
| Book Value Per Share | 21.77 X | ||||
| Cash Flow From Operations | 220.8 M | ||||
| Earnings Per Share | 1.65 X | ||||
| Price To Earnings To Growth | 1.70 X | ||||
| Target Price | 76.22 | ||||
| Number Of Employees | 7.4 K | ||||
| Beta | 0.61 | ||||
| Market Capitalization | 4.09 B | ||||
| Total Asset | 2.42 B | ||||
| Retained Earnings | 695.54 M | ||||
| Working Capital | 707.37 M | ||||
| Net Asset | 2.42 B |
About Merit Medical Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Merit Medical Systems's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Merit Medical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Merit Medical Systems based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
| FSLY | Fastly Class A | |
| MOB | Mobilicom Limited American | |
| CMG | Chipotle Mexican Grill | |
| CSAN | Cosan SA ADR | |
| RKT | Rocket Companies |
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Merit Medical Systems. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in inflation. You can also try the ETFs module to find actively traded Exchange Traded Funds (ETF) from around the world.